Humanigen Inc (HGENQ)

[cowtown jay]

"Michael North
Co-Founder, CEO; Chairman of Galaxy Magnesium

1mo

I have agreed to serve Taran Therapeutics as Strategy Advisor. Taran is a leader in the field of monocolonal antibody therapies, and I provide communications with prospective investors and key stakeholders. I work directly with the chief executives of the company, Cameron Durrant and Michael Schuster, helping to formulate its mission, vision, and long-term investment strategy. This is especially meaningful to me, because of my long commitment to the life sciences, specifically to making fundamental therapies that penetrate to root causes widely available."

https://www.linkedin.com/posts/michaelnorth_i-have-agreed-to-serve-taran-therapeutics-activity-7183247229166534657-j50L

Michael W Schuster, MD

Hematology Oncology, Hematology

https://doctors.stonybrookmedicine.edu/provider/Michael+W+Schuster/2250408

Schuster seems to have had a role in the following Pfizer clinical trial

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

https://clinicaltrials.gov/study/NCT04842604?intr=NCT02367456.&rank=1